The multitarget-directed ligands approach represents a potential strategy to provide effective treatments for Alzheimer's disease (AD) given its multifactorial pathology. Herein, a series of N-benzyl piperidine derivatives were designed, synthesized, and biologically characterized for dual inhibitions of histone deacetylase (HDAC) and acetylcholinesterase (AChE). Among the compounds tested, d5 and d10 exhibited dual enzyme inhibitions (d5: HDAC = 0.17 μM, AChE = 6.89 μM, d10: HDAC = 0.45 μM, AChE = 3.22 μM), and both compounds showed activities on scavenging free radical, metal chelating, and inhibiting Aβ aggregations. More importantly, both compounds exhibited promising neuroprotective activities in PC-12 cells and good AChE selectivity. Collectively, the multifunctional profiles of compound d5 and d10 encourage further optimization and exploration to develop more potent analogues as potential treatments for AD.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.bmc.2023.117178 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Stereodivergent Synthesis of Aldol Products Using Pseudo-C Symmetric -benzyl-4-(trifluoromethyl)piperidine-2,6-dione.
Molecules
October 2024
Division of Applied Chemistry, Institute of Engineering, Tokyo University of Agriculture and Technology, 2-24-16 Nakamachi, Koganei 184-8588, Japan.
The present article describes the successful performance of crossed aldol reactions of the CF-containing pseudo-C symmetric cyclic imide with various aldehydes. The utilization of HMPA as an additive attained the preferential formation of the -products in good to excellent yields, which contrasts with our previous method without this additive, proceeding to furnish the corresponding -isomers. The effective participation of ketones and α,β-unsaturated carbonyl compounds in reactions with this imide was also demonstrated to expand the application of this imide.
View Article and Find Full Text PDFN-Benzyl piperidine Fragment in Drug Discovery.
ChemMedChem
October 2024
Natural Products & Medicinal Chemistry Division, CSIR-Indian Institute of Integrative Medicine, Canal Road, Jammu, 180001, India.
Article Synopsis
- - The N-benzyl piperidine (N-BP) motif is an important structural element in drug discovery, known for its flexibility and ability to interact with target proteins.
- - Medicinal chemists leverage the N-BP motif to enhance drug efficacy and optimize properties related to potency and toxicity, identifying its relevance in existing and emerging therapies.
- - The review highlights the N-BP motif's applications in drug development, including its presence in approved drugs and ongoing clinical trials, while also addressing potential challenges in its use for various therapeutic targets.
Synthesis, biological evaluation, and computational studies of -benzyl pyridinium-curcumin derivatives as potent AChE inhibitors with antioxidant activity.
J Enzyme Inhib Med Chem
December 2023
Resonance Research Lab, Amman, Jordan.
A library of -benzylpyridinium-based compounds, and , was designed and synthesised as potential acetylcholinesterase) AChE (inhibitors. An assay for the synthesised compounds showed that most compounds had significant AChE inhibitory activities at the nanomolar and submicromolar levels. The benzyl () and fluoro () derivatives were the most active, with IC values ≤56 nM.
View Article and Find Full Text PDFStructure-based design of new N-benzyl-piperidine derivatives as multitarget-directed AChE/BuChE inhibitors for Alzheimer's disease.
J Cell Biochem
November 2023
Laboratory of Molecular Modeling & QSAR (ModMolQSAR), Faculty of Pharmacy, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
The pathogenic complexity of Alzheimer's disease (AD) demands the development of multitarget-directed agents aiming at improving actual pharmacotherapy. Based on the cholinergic hypothesis and considering the well-established role of butyrylcholinesterase (BuChE) in advanced stages of AD, the chemical structure of the acetylcholinesterase (AChE) inhibitor drug donepezil (1) was rationally modified for the design of new N-benzyl-piperidine derivatives (4a-d) as potential multitarget-direct AChE and BuChE inhibitors. The designed analogues were further studied through the integration of in silico and in vitro methods.
View Article and Find Full Text PDFControlling cell proliferation by targeting cyclin-dependent kinase 6 using drug repurposing approach.
Adv Protein Chem Struct Biol
April 2023
Laboratory of Integrative Genomics, Department of Integrative Biology, School of Bio Sciences and Technology, Vellore Institute of Technology (VIT), Vellore, Tamil Nadu, India. Electronic address:
Article Synopsis
- CDK6 is a crucial protein kinase involved in the cell cycle, making it a potential target for cancer treatments, especially for breast cancer, and this study aims to identify promising new compounds through a drug repurposing strategy.
- The research found two compounds that bind more effectively to CDK6 than the common drug abemaciclib, showing significant binding affinities and similar absorption, distribution, metabolism, and excretion (ADME) properties.
- Molecular dynamics simulations suggested that these compounds maintain stability and interactions with CDK6, indicating their potential as effective inhibitors that warrant further laboratory testing.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!